Zusammenfassung
Die Mitralklappenerkrankungen zählen zu den häufigsten Herzklappenerkrankungen. Für die primäre Mitralinsuffizienz (MI) ist die chirurgische Mitralklappenrekonstruktion (MKR) die Therapie der Wahl, welche mit einem exzellenten Outcome und Langzeitüberleben in ausgewiesenen Zentren durchgeführt werden kann. Die operative Technik der MKR ist abhängig vom Pathomechanismus, von den morphologischen Dimensionen der Mitralklappe, vom operativen Risiko des Patienten sowie von der Expertise des Herzchirurgen. Die chirurgische und interventionelle Behandlung der sekundären MI ist Gegenstand anhaltender Diskussion. Hierbei sollte die moderate sekundäre MI durch eine chirurgische MKR bei gleichzeitiger Bypass-Versorgung versorgt werden. Bei schwerer sekundärer MI sollte, bei Vorhandensein von Risikofaktoren für ein mögliches Misslingen einer MKR, von vornherein ein Mitralklappenersatz (MKE) durchgeführt werden. Die selten gewordene Mitralklappenstenose sollte unter Berücksichtigung der Pathophysiologie, der Nebenerkrankungen, der notwendigen Antikoagulation sowie des Lebensalters mit einem biologischen oder mechanischen MKE behandelt werden. Des Weiteren bieten neue katheterbasierte Techniken des MKE weitere Behandlungsoptionen zur Reoperation von Hochrisikopatienten.
Abstract
Mitral valve (MV) disease is one of the most common heart valve diseases. The surgical and interventional treatment for MV disease requires a multidisciplinary approach. For primary mitral valve regurgitation (MVR) surgical MV repair is the treatment of choice, which can be performed with an excellent outcome and long-term survival in reference centers. The surgical technique used for MV repair depends on the pathological mechanism, the morphological dimensions of the MV, the operative risk and the expertise of the cardiac surgeon. The surgical and interventional treatment of secondary MVVR is the subject of on-going discussions. In patients with moderate secondary MVR undergoing coronary artery bypass grafting, concomitant MV repair should be performed. In the presence of severe secondary MR with risk factors for failure of MV repair, patients should consider having MV replacement. In the rare cases of patients presenting with mitral valve stenosis (MVS) MV repair can be considered in young patients and who are most often treated with MV replacement. The choice between biological or mechanical MV replacement depends on the pathophysiology, the comorbidities, the amount of anticoagulation necessary and the age of the patient. New percutaneous techniques for MV replacement offer new treatment options for reoperation in high-risk patients.
Literatur
Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS et al (2006) Burden of valvular heart diseases: a population-based study. Lancet 368(9540):1005–1011
Iung B, Vahanian A (2011) Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol 8(3):162–172
Meinertz T, Diegeler A, Stiller B, Fleck E et al (2015) German Heart Report 2013. Clin Res Cardiol 104(2):112–123
Gaemperli O, Corti R (2012) MitraClip for the treatment of mitral regurgitation. Cardiovascular Med 15(10):276–286
Avierinos JF, Gersh BJ, Melton LJ III, Bailey KR et al (2002) Natural history of asymptomatic mitral valve prolapse in the community. Circulation 106(11):1355–1361
Bursi F, Enriquez-Sarano M, Nkomo VT, Jacobsen SJ et al (2005) Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation 111(3):295–301
Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, Detaint D et al (2005) Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 352(9):875–883
Vahanian A, Alfieri O, Andreotti F, Antunes MJ et al (2012) Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 42(4):S1–S44
Castillo JG, Solís J, González-Pinto Á, Adams DH (2011) Surgical echocardiography of the mitral valve. Rev Esp Cardiol 64(12):1169–1181
Holzhey DM, Seeburger J, Misfeld M, Borger MA et al (2013) Learning minimally invasive mitral valve surgery: a cumulative sum sequential probability analysis of 3895 operations from a single high-volume center. Circulation 128(5):483–491
Beckmann A, Funkat AK, Lewandowski J, Frie M et al (2015) Cardiac surgery in Germany during 2014: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 63(4):258–269
Iung B, Baron G, Butchart EG, Delahaye F et al (2003) A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 24(13):1231–1243
Habib G, Lancellotti P, Antunes MJ, Bongiorni MG et al (2015) 2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC) Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 36:3075–3123. doi:10.1093/eurheartj/ehv319
The Society of Thoracic Surgeons Adult Cardiac Database (2011) http://www.sts.org/national-database
Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA et al (2013) Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 14(7):611–644
Carpentier A, Adams DH, Filsoufi F (2010) Carpentier’s reconstructive valve surgery. From valve analysis to valve reconstruction. Saunders Elsevier, Maryland Heights. doi:10.1016/j.jss.2011.05.013
Vahanian A, Lung B, Pierard L, Dion R et al (2009) Valvular heart disease. In: Camm AJ, Luescher TF (eds) The ESC textbook of cardiovascular medicine, 2nd edn. Blackwell Publishing Ltd, Malden, pp 625–670
De Bonis M, Al-Attar N, Antunes M, Borger M et al (2015) Surgical and interventional management of mitral valve regurgitation: a position statement from the European Society of Cardiology Working Groups on Cardiovascular Surgery and Valvular Heart Disease. Eur Heart J doi:http://dx.doi.org/10.1093/eurheartj/ehv322. (First published online: 7 July 2015)
Lang RM, Badano LP, Tsang W, Adams DH et al (2012) EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. Eur Heart J Cardiovasc Imaging 13(1):1–46
Noack T, Mukherjee C, Kiefer P, Emrich F et al (2015) Four-dimensional modelling of the mitral valve by real-time 3D transoesophageal echocardiography: proof of concept. Interact Cardiovasc Thorac Surg 20(2):200–208
Ionasec RI, Voigt I, Georgescu B, Wang Y et al (2010) Patient-specific modeling and quantification of the aortic and mitral valves from 4-D cardiac CT and TEE. IEEE Trans Med Imaging 29(9):1636–1651
Jassar AS, Brinster CJ, Vergnat M, Robb JD et al (2011) Quantitative mitral valve modeling using real-time three-dimensional echocardiography: technique and repeatability. Ann Thorac Surg 91(1):165–171
Noack T, Kiefer P, Ionasec R, Voigt I et al (2013) New concepts for mitral valve imaging. Ann Cardiothorac Surg 2(6):787–795
Sündermann SH, Falk V (2014) Zur Leitlinie Herzklappenerkrankungen der ESC und EACTS Version 2012. Z Herz Thorax Gefäßchir 28(2):120–126
Seeburger J, Noack T, Winkfein M, Ender J et al (2010) Loop technique. Multimed Man Cardiothorac Surg 2010(809):mmcts 2010.004523
Seeburger J, Borger MA, Falk V, Kuntze T et al (2008) Minimal invasive mitral valve repair for mitral regurgitation: results of 1339 consecutive patients. Eur J Cardiothorac Surg 34(4):760–765
Seeburger J, Falk V, Borger MA, Passage J et al (2009) Chordae replacement versus resection for repair of isolated posterior mitral leaflet prolapse: à ègalité. Ann Thorac Surg 87(6):1715–1720
Rosenhek R, Rader F, Klaar U, Gabriel H et al (2006) Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation 113(18):2238–2244
Vassileva CM, Mishkel G, McNeely C, Boley T et al (2013) Long-term survival of patients undergoing mitral valve repair and replacement: a longitudinal analysis of Medicare fee-for-service beneficiaries. Circulation 127(18):1870–1876
Castillo JG, Anyanwu AC, Fuster V, Adams DH (2012) A near 100 % repair rate for mitral valve prolapse is achievable in a reference center: implications for future guidelines. J Thorac Cardiovasc Surg 144(2):308–312
Gillinov AM, Blackstone EH, Nowicki ER, Slisatkorn W et al (2008) Valve repair versus valve replacement for degenerative mitral valve disease. J Thorac Cardiovasc Surg 135(4):885–893, 893.e881–e882
Perier P, Hohenberger W, Lakew F, Batz G et al (2013) Rate of repair in minimally invasive mitral valve surgery. Ann Cardiothorac Surg 2(6):751–757
Vassileva CM, McNeely C, Spertus J, Markwell S et al (2015) Hospital volume, mitral repair rates, and mortality in mitral valve surgery in the elderly: an analysis of US hospitals treating Medicare fee-for-service patients. J Thorac Cardiovasc Surg 149(3)762–768.e761
Vassileva CM, Boley T, Markwell S, Hazelrigg S (2012) Impact of hospital annual mitral procedural volume on mitral valve repair rates and mortality. J Heart Valve Dis 21(1):41–47
David TE, Armstrong S, McCrindle BW, Manlhiot C (2013) Late outcomes of mitral valve repair for mitral regurgitation due to degenerative disease. Circulation 127(14):1485–1492
DiBardino DJ, ElBardissi AW, McClure RS, Razo-Vasquez OA et al (2010) Four decades of experience with mitral valve repair: analysis of differential indications, technical evolution, and long-term outcome. J Thorac Cardiovasc Surg 139(1):76–83 (discussion 83–84)
Acker MA, Parides MK, Perrault LP, Moskowitz AJ et al (2014) Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med 370(1):23–32
Borger MA, Alam A, Murphy PM, Doenst T et al (2006) Chronic ischemic mitral regurgitation: repair, replace or rethink? Ann Thorac Surg 81(3):1153–1161
Casselman F, Martens S, De Bruyne B, Degrieck I (2011) Reducing operative mortality in valvular reoperations: the „valve in ring“ procedure. J Thorac Cardiovasc Surg 141(5):1317–1318
Descoutures F, Himbert D, Maisano F, Casselman F et al (2013) Transcatheter valve-in-ring implantation after failure of surgical mitral repair. Eur J Cardiothorac Surg 44(1):e8–e15
Wilbring M, Alexiou K, Tugtekin SM, Arzt S et al (2014) Pushing the limits – further evolutions of transcatheter valve procedures in the mitral position, including valve-in-valve, valve-in-ring, and valve-in-native-ring. J Thorac Cardiovasc Surg 147(1):210–219
Alsidawi S, Eleid MF, Rihal CS, Nkomo VT et al (2015) Significant LVOT obstruction after mitral valve in ring procedure. Eur Heart J Cardiovasc Imaging doi:http://dx.doi.org/10.1093/ehjci/jev235. (First published online: 29 September 2015)
Bapat V, Pirone F, Kapetanakis S, Rajani R et al (2015) Factors influencing left ventricular outflow tract obstruction following a mitral valve-in-valve or valve-in-ring procedure, part 1. Catheter Cardiovasc Interv 86(4):747–760
Allende R, Doyle D, Urena M, Ribeiro HB et al (2015) Transcatheter mitral „valve-in-ring“ implantation: a word of caution. Ann Thorac Surg 99(4):1439–1442
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
T. Noack und F.-W. Mohr geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Noack, T., Mohr, FW. Operative Techniken bei Mitralklappenerkrankungen. Herz 41, 10–18 (2016). https://doi.org/10.1007/s00059-015-4385-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00059-015-4385-1